Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers.
Saved in:
| Title: | Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers. |
|---|---|
| Authors: | Atallah, Bassam1,2 (AUTHOR) Atallab@clevelandclinicabudhabi.ae, El Nekidy, Wasim1,2 (AUTHOR), Mallah, Saad I.3 (AUTHOR), Cherfan, Antoine1 (AUTHOR), AbdelWareth, Laila4 (AUTHOR), Mallat, Jihad2,5,6 (AUTHOR), Hamed, Fadi5 (AUTHOR) |
| Source: | Thrombosis Journal. 9/9/2020, Vol. 18 Issue 1, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14779560 |
|---|---|
| DOI: | 10.1186/s12959-020-00236-9 |